Tuesday, August 13, 2024

23andMe drops drug discovery group, expands Lemonaid into GLP-1 weight loss medications, loses $69M in Q1–and board rejects CEO’s buyout offer


via Latest News – Telehealth and Telecare Aware https://ift.tt/ab2Et0Y telehealthsuppliers.com
Posted by at
Labels: , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)